Literature DB >> 12948866

Alpha-lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes.

Kyung-Joo Cho1, Hadi Moini, Hee-Kyung Shon, An-Sik Chung, Lester Packer.   

Abstract

Alpha-lipoic acid is known to increase insulin sensitivity in vivo and to stimulate glucose uptake into adipose and muscle cells in vitro. In this study, alpha-lipoic acid was demonstrated to stimulate the autophosphorylation of insulin receptor and glucose uptake into 3T3-L1 adipocytes by reducing the thiol reactivity of intracellular proteins. To elucidate mechanism of this effect, role of protein thiol groups and H(2)O(2) in insulin receptor autophosphorylation and glucose uptake was investigated in 3T3-L1 adipocytes following stimulation with alpha-lipoic acid. Alpha-lipoic acid or insulin treatment of adipocytes increased intracellular level of oxidants, decreased thiol reactivity of the insulin receptor beta-subunit, increased tyrosine phosphorylation of the insulin receptor, and enhanced glucose uptake. Alpha-lipoic acid or insulin-stimulated glucose uptake was inhibited (i) by alkylation of intracellular, but not extracellular, thiol groups downstream of insulin receptor activation, and (ii) by diphenylene iodonium at the level of the insulin receptor autophosphorylation. alpha-Lipoic acid also inhibited protein tyrosine phosphatase activity and decreased thiol reactivity of protein tyrosine phosphatase 1B. These findings indicate that oxidants produced by alpha-lipoic acid or insulin are involved in activation of insulin receptor and in inactivation of protein tyrosine phosphatases, which eventually result in elevated glucose uptake into 3T3-L1 adipocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948866     DOI: 10.1016/s0006-2952(03)00395-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by alpha-lipoic acid through PI3 kinase, PTEN, and PP2A.

Authors:  Kate Petersen Shay; Tory M Hagen
Journal:  Biogerontology       Date:  2008-10-18       Impact factor: 4.277

Review 2.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Authors:  Kate Petersen Shay; Régis F Moreau; Eric J Smith; Anthony R Smith; Tory M Hagen
Journal:  Biochim Biophys Acta       Date:  2009-08-04

3.  The protective role of DL-alpha-lipoic acid in the oxidative vulnerability triggered by Abeta-amyloid vaccination in mice.

Authors:  E Philip Jesudason; J Gunasingh Masilamoni; K Samuel Jesudoss; R Jayakumar
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study.

Authors:  Harsh Sancheti; Ishan Patil; Keiko Kanamori; Roberta Díaz Brinton; Wei Zhang; Ai-Ling Lin; Enrique Cadenas
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-06       Impact factor: 6.200

5.  Lipoic acid restores age-associated impairment of brain energy metabolism through the modulation of Akt/JNK signaling and PGC1α transcriptional pathway.

Authors:  Tianyi Jiang; Fei Yin; Jia Yao; Roberta D Brinton; Enrique Cadenas
Journal:  Aging Cell       Date:  2013-07-29       Impact factor: 9.304

6.  Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a 13C NMR study.

Authors:  Harsh Sancheti; Keiko Kanamori; Ishan Patil; Roberta Díaz Brinton; Brian D Ross; Enrique Cadenas
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-13       Impact factor: 6.200

7.  Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling.

Authors:  Lester Packer; Enrique Cadenas
Journal:  J Clin Biochem Nutr       Date:  2010-12-29       Impact factor: 3.114

8.  Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer's disease.

Authors:  Harsh Sancheti; Garnik Akopian; Fei Yin; Roberta D Brinton; John P Walsh; Enrique Cadenas
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.